L Y. Dirix
Affiliations: | Universiteit Antwerpen (Belgium) |
Area:
Oncology, Molecular Biology, Biostatistics BiologyGoogle:
"L Dirix"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bartlett JMS, Xu K, Wong J, et al. (2024) Validation of the prognostic performance of Breast Cancer Index (BCI) in hormone receptor-positive (HR+) postmenopausal breast cancer patients in the TEAM trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| De Schepper M, Nguyen HL, Richard F, et al. (2023) Treatment response, tumor infiltrating lymphocytes and clinical outcomes in inflammatory breast cancer treated with neoadjuvant systemic therapy. Cancer Research Communications |
| Wildiers H, Armstrong A, Cuypere E, et al. (2023) Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase 2b Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Richard F, De Schepper M, Maetens M, et al. (2023) Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target. Breast (Edinburgh, Scotland) |
| Xu K, Bayani J, Mallon E, et al. (2022) Discordance between Immunohistochemistry and ERBB2 mRNA to Determine HER2 Low Status for Breast Cancer. The Journal of Molecular Diagnostics : Jmd |
| Dirix L, Buys A, Oeyen S, et al. (2022) Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer. Breast Cancer Research and Treatment |
| Gerratana L, Pierga JY, Reuben JM, et al. (2022) Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation. The Oncologist |
| Dirix LY, Oeyen S, Buys A, et al. (2022) Coagulation/fibrinolysis and circulating tumor cells in patients with advanced breast cancer. Breast Cancer Research and Treatment |
| Fitzpatrick A, Iravani M, Mills A, et al. (2021) Assessing CSF ctDNA to improve diagnostic accuracy and therapeutic monitoring in breast cancer leptomeningeal metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Lindgren M, Jansson M, Tavelin B, et al. (2021) Type IV collagen as a potential biomarker of metastatic breast cancer. Clinical & Experimental Metastasis. 38: 175-185 |